Life Science Company
Sanofi SA has acquired 24 companies, including 4 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 14 assets.
Sanofi SA’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2018, when it sold Zentiva Group a.s. to Advent International for $2.2B. Sanofi SA has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include life science (60%) and medical products (19%).
Join Mergr and gain access to Sanofi SA’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity36
- M&A Buy Activity22
- M&A Sell Activity14
- Total Sectors Invested 5
- Total Countries Invested 9
- M&A Buy/Sell Connections 24
- M&A Advisors 6
Unlimited Searches
